Effects of chlordiazepoxide on opioid-induced antinociception and respiratory depression in restrained rats

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 3, 1998, Pages 663-670

  Verborgh, Christian ^a   De Coster, Roland ^b   D'Haese, Jan ^a   Camu, Frederic ^a   Meert, Theo F ^b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Adrenocorticotropic hormone; Chlordiazepoxide; Corticosterone; Morphine; Prolactin; Restraint stress; Stress induced analgesia; Sufentanil

Indexed keywords

CHLORDIAZEPOXIDE; MORPHINE; OPIATE; PROLACTIN; SUFENTANIL;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BLOOD GAS; CORTICOSTEROID BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION; STRESS; TAIL FLICK TEST;

ADRENAL CORTEX HORMONES; ANALGESICS, OPIOID; ANIMALS; ANTI-ANXIETY AGENTS; AREA UNDER CURVE; BLOOD GAS ANALYSIS; CHLORDIAZEPOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHINE; NOCICEPTORS; PAIN MEASUREMENT; RATS; RATS, WISTAR; RESPIRATORY INSUFFICIENCY; RESPIRATORY MECHANICS; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; SUFENTANIL;

ANIMALIA;

EID: 0032032939     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00441-3     Document Type: Article

References (37)

1. Aguilera G., Kiss A., Sunar-Akbasak B. Hyperreninemic hypoaldosteronism after chronic stress in the rat. J. Clin. Invest. 96:1995;1512-1519.
2. Alexander C. M., Gross J. B. Sedative doses of midazolam depress hypoxic ventilatory responses in humans. Anesth. Analg. 67:1988;377-382.
3. Appelbaum B. D., Holtzman S. G. Characterization of stress-induced potentiation of opioid effects in the rat. J. Pharmacol. Exp. Ther. 231:1984;555-565.
4. Appelbaum B. D., Holtzman S. G. Stress-induced changes in the analgesic and thermic effects of opioid peptides in the rat. Brain. Res. 377:1986;330-336.
5. Bero L. A., Lurie S. N., Kuhn C. M. Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat. Brain Res. 465:1987;189-196.
6. Bhattacharya S. K., Keshary P. R., Sanyal A. K. Immobilisation stress-induced antinociception in rats. Possible role of serotonin and prostaglandins Eur. J. Pharmacol. 50:1978;83-85.
7. Bianchi M., Mantegazza P., Tammiso R., Zonta N., Zambotti F. Peripherally administered benzodiazepines increase morphine-induced analgesia in the rat. Effect of RO 15-3505 and FG 7142. Arch. Int. Pharmacodyn. Ther. 322:1993;5-13.
8. Buckingham J. C., Cooper T. A. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocrinology. 38:1984;411-417.
9. De Boer S. F., Van der Gugten J., Slangen J. L. Brain benzodiazepine receptor-mediated effects on plasma catecholamine and corticosterone concentrations in rats. Brain Res. Bull. 24:1990;843-847.
10. De Boer S. F., Van der Gugten J., Slangen J. L. Effects of chlordiazepoxide, flumazenil and DMCM on plasma catecholamine and corticosterone concentrations in rats. Pharmacol. Biochem. Behav. 38:1991;13-19.
11. De Langhe S., Stanley T. H., Boscoe M. J., De Bruijn N., Berman L., Green O., Robertson D. Catecholamine and cortisol responses to sufentanil-O2 and alfentanil-O2 anaesthesia during coronary artery surgery. Can. Anaesth. Soc. J. 30:1983;248-254.
12. File S. E., Rodgers R. J. Partial anxiolytic action of morphine sulphate following microinjection into the central nucleus of the amygdala in rats. Pharmacol. Biochem. Behav. 11:1979;313-318.
13. Fleetwood S. W., Holtzman S. G. Stress-induced potentiation of morphine-induced analgesia in morphine-tolerant rats. Neuropharmacology. 28:1989;563-567.
14. Forster A., Gardaz J. P., Suter P. M., Gemperle M. Respiratory depression by midazolam and diazepam. Anesthesiology. 53:1980;494-497.
15. Forster A., Morel D., Bachmann M., Gemperle M. Respiratory depressant effects of different doses of midazolam and lack of reversal with naloxone. A double-blind randomized study Anesth. Analg. 62:1983;920-924.
16. Furst S. Pharmacological interaction of opiates with various classes of centrally acting dopaminergic drugs. Drug. Metabol. Drug. Interact. 9:1991;77-102.
17. Harbuz M. S., Chalmers J., De Souza L., Lightman S. L. Stress-induced activation of CRF and c-fos mRNAs in the paraventricular nucleus are not affected by serotonin depletion. Brain Res. 609:1993;167-173.
18. Hayes A. G., Stewart B. R. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels. Eur. J. Pharmacol. 116:1985;75-79.
19. Janssen P. A. J. Potent, new analgesics; Tailor-made for different purposes. Acta. Anesthesiol. Scand. 26:1982;262-268.
20. Kant G. J., Bunnell B. N., Mougey E. H., Pennington L. L., Meyerhoff J. L. Effects of repeated stress on pituitary cyclic AMP, and plasma prolactin, corticosterone and growth hormone in male rats. Pharmacol. Biochem. Behav. 18:1983;967-971.
21. Kiss A., Jezova D., Aguilera G. Activity of the hypothalamic pituitary adrenal axis and sympathoadrenal system during food and water deprivation in the rat. Brain Res. 663:1994;84-92.
22. Kleinman J., Marlar K., Silva D. A., Miller R., Kaplan J. A. Sufentanil attenuation of the stress response during rapid sequence induction. Anesthesiology. 63:1985;A379.
23. Kurumaji A., Takashima M., Shibuya H. Cold and immobilization stress-induced changes in pain responsiveness and brain Met-enkephalin-like immunoreactivity in the rat. Peptides. 8:1987;355-359.
24. Levesque D., Holtzman S. G. The potentiating effects of restraint stress and continuous naloxone infusion on the analgesic potency or morphine are additive. Brain. Res. 617:1993;176-180.
25. Lopez-Calderon A., Ariznavarreta C., Chen C. L. Influence of chronic restraint stress on pro-opiomelanocortin mRNA and beta-endorphin in the rat hypothalamus. J. Mol. Endocrinol. 7:1991;197-204.
26. Luger T.J., Hayashi T., Weiss C. G., Hill H. F. The spinal potentiating effect and the supraspinal inhibitory effect of midazolam on opioid-induced analgesia in rats. Eur. J. Pharmacol. 275:1995;153-162.
27. Milanes M. V., Puig M. M., Vargas M. L. Simultaneous changes in hypothalamic catecholamine levels and plasma corticosterone concentration in the rat after acute morphine and during tolerance. Neuropeptides. 24:1993;279-284.
28. Mora C. T., Torjman M., White P. F. Effects of diazepam and flumazenil on sedation and hypoxic ventilatory response. Anesth. Analg. 68:1989;473-478.
29. Mormede P., Dantzer R., Perio A. Relationship of the effects of the benzodiazepine derivative clorazepate on corticosterone secretion with its behavioural actions. Antagonism by Ro 15-1788. Pharmacol. Biochem. Behav. 21:1984;839-843.
30. Palaoglu O., Ayhan I. H. The possible role of benzodiazepine receptors in morphine analgesia. Pharmacol. Biochem. Behav. 25:1986;215-217.
31. Pechnick R., George R., Poland R. E. Identification of multiple opiate receptors through neuroendocrine responses. I. Effects of agonists. J. Pharmacol. Exp. Ther. 232:1985;163-169.
32. Rodgers R. J., Randall J. I. Benzodiazepine ligands, nociception and 'defeat' analgesia in male mice. Psychopharmacology (Berlin). 91:1987;305-315.
33. Tanaka M., Tsuda A., Yokoo H., Yoshida M., Mizoguchi K., Shimizu T. Psychological stress-induced increases in noradrenaline release in rat brain regions are attenuated by diazepam, but not by morphine. Pharmacol. Biochem. Behav. 39:1991;191-195.
34. Trudeau L. E., Aragon C. M., Amit Z. Effects of ethanol on locomotor depression and corticosterone release induced by restraint-stress. Support for a stress-ethanol interaction Pharmacol. Biochem. Behav. 36:1990;273-278.
35. Verborgh C., Meert T. F. Interactions between sufentanil and U-50488H in terms of antinociception and respiratory depression in rats. Dolor. 11:1996;52.
36. Williams C. L., Villar R. G., Peterson J. M., Burks T. F. Stress-induced changes in intestinal transit in the rat. A model for irritable bowel syndrome Gastroenterology. 94:1988;611-621.
37. Woolfolk D. R., Holtzman S. G. Rat strain differences in the potentiation of morphine-induced analgesia by stress. Pharmacol. Biochem. Behav. 51:1995;699-703.